Print

Print


The fight is not over; it has just begun.
and I'm very tired.

Ray

Susan L. Solomon
CEO, The New York Stem Cell Foundation
Posted March 9, 2009 | 11:37 AM (EST)

For the last eight years, human embryonic stem cell research -- which is 
improving our understanding of how we can treat and defeat diseases such as 
Parkinson's and diabetes -- has been a hostage of presidential politics. 
Monday's executive order by President Barack Obama changes that, lifting 
many restrictions on federal funding for research on new stem cell lines 
derived from human embryos. Unfortunately, this stroke of the pen does not 
remove key legislative hurdles that will continue to prevent federal dollars 
from being spent on this critical science.
Stem cell research represents the most revolutionary area of medical 
research today, opening possibilities for treating cancer, diabetes, Lou 
Gehrig's disease, blindness and paralysis. The previous administration's ban 
cost researchers precious time in the race for new cures, treatments and 
discoveries. TIME magazine recently cited a New York Stem Cell 
Foundation-funded breakthrough by Dr. Kevin Eggan as the most significant 
scientific achievement in 2008. Because of the ban on federal funding, this 
groundbreaking work was only possible through the generosity of private 
donors.

President Obama's symbolic decision to address this transforming medical 
issue will ultimately give laboratories nationwide new resources to change 
lives. But while the new administration brings a refreshingly friendly 
attitude toward science, in general, and stem cell research in particular, 
researchers will still lack easy access to the full range of possibilities 
that stem cells present.
Significant obstacles remain in the path of stem cell research progress. The 
president possesses unilateral authority only to allow federal funding of 
research on new and existing embryonic stem cell lines -- he cannot 
single-handedly green-light federal funding to create the stem cell lines 
themselves. That's because Congress in 1996 banned the use of human embryos, 
even those discarded in fertility clinics or voluntarily made for scientific 
purposes, for research purposes -- including the creation of embryonic stem 
cells. That piece of legislation, the so-called Dickey-Wicker Amendment, is 
inextricably linked to abortion politics, and is unlikely to be removed from 
the books in the near future.

It is crucial to our ultimate success to allow wide access to all of the 
stem cell lines that have already been created from embryos, as well as to 
continue to create new lines for comparative and other purposes, including 
the research that can only be done with human embryonic stem cells. 
Researchers throughout the world feel that the new "induced pluripotentiary 
stem cells" (iPS for short) are powerful tools for scientists studying the 
mechanisms of human disease in their laboratories. However, scientists agree 
that human embryonic stem cells remain the "gold standard" of research, 
making the production of new stem cells of urgent importance.
Private funding sources like NYSCF, which are by nature far more nimble than 
government agencies, are still essential to advancing stem cell research. 
Private philanthropy is, and will continue to be, a critical and necessary 
driver of the most innovative and promising stem cell science.
We cannot continue to ask our best scientists to work with one hand tied 
behind their backs. Finding better treatments and cures for these terrible 
diseases is urgent work. The New York Stem Cell Foundation will continue to 
use private philanthropy to ensure that scientists are able to perform the 
experiments that simply wouldn't be funded or initiated elsewhere, which 
will continue to change the way scientists and the public view what is 
possible in this burgeoning medical area. And we hope that Congress will act 
quickly, once and for all, to put patients before politics by putting 
science first.

Rayilyn Brown
Director AZNPF
Arizona Chapter National Parkinson Foundation
[log in to unmask] 

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn